## PH: Parker-Hannifin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.1% below STRENGTH zone (4.0-10.0%); PEG 3.40 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (46% of avg), momentum weakening (-3.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($822.30)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Parker-Hannifin (PH) Stock on November 29, 2025: Analyst Downgrade, Big Money Flows and a $9.25 Billion Filtration Bet**
- Source: ts2.tech | 20251130T103714 | Somewhat-Bullish | Relevance: 99%
- Parker-Hannifin (PH) stock is trading near record highs as of November 29, 2025, despite a recent downgrade from "Buy" to "Hold" by Wall Street Zen due to valuation concerns. The company is actively digesting its $9.25 billion Filtration Group acquisition and reported strong fiscal 2026 Q1 results with raised guidance. Institutional investors show mixed activity, with some trimming positions for profit-taking, while long-only investors and pensions are increasing their stakes, reflecting continued confidence in the company's long-term strategy, including its expansion into filtration and electrification.

**2. Panagora Asset Management Inc. Lowers Holdings in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251202T123133 | Neutral | Relevance: 99%
- Panagora Asset Management Inc. reduced its stake in Parker-Hannifin Corporation by 1.6% in Q2 2025, holding 171,128 shares valued at $119.53 million. Despite this, Parker-Hannifin reported strong Q2 EPS and revenue, issued robust FY2026 guidance, and maintains a "Moderate Buy" consensus rating from analysts with an $860.71 price target. The company also announced a quarterly dividend of $1.80 per share, while insider selling by VPs materially reduced their holdings.

**3. Is Parker-Hannifin Stock Outperforming the S&P 500?**
- Source: Barchart.com | 20251201T093637 | Bullish | Relevance: 99%
- Parker-Hannifin Corporation (PH) has shown strong performance, outperforming the S&P 500 Index ($SPX) across various timeframes, driven by robust organic growth in aerospace and defense and improved industrial operations. The company delivered impressive Q1 results, surpassing Wall Street expectations for both EPS and revenue, and analysts maintain a "Strong Buy" rating with a potential upside. PH's global presence and strategic management of currency risks also contribute to its stable growth and market dominance.

**4. Loomis Sayles & Co. L P Purchases 815 Shares of Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251130T122252 | Bullish | Relevance: 99%
- Loomis Sayles & Co. L P increased its stake in Parker-Hannifin Corporation by 815 shares, bringing its total holdings to 384,993 shares valued at approximately $268.9 million. The article details Parker-Hannifin's strong financial performance including an EPS beat and revenue above estimates, and provides information on other institutional investments, stock performance metrics, dividend announcements, analyst ratings, and insider trading activity.

**5. West Family Investments Inc. Makes New $434,000 Investment in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251201T133827 | Bullish | Relevance: 98%
- West Family Investments Inc. has made a new $434,000 investment in Parker-Hannifin Corporation, acquiring 621 shares. This move follows substantial investments by other institutional investors like Norges Bank and Nuveen LLC, with institutional holdings now accounting for 82.44% of the stock. Parker-Hannifin recently surpassed quarterly earnings estimates and announced an annualized dividend of $7.20.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $1006 | $960 | +5% |
| 2025-12-04 | Barclays | $950 | $906 | +5% |
| 2025-11-12 | Baird | $960 | $930 | +3% |
| 2025-11-12 | Susquehanna | $1000 | $960 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Buy |
| 2025-12-04 | Barclays | main | Overweight |
| 2025-11-12 | Baird | main | Outperform |
| 2025-11-12 | Susquehanna | main | Positive |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 4 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.1%)
- Blackrock Inc.: 7.8% (+0.6%)
- State Street Corpora: 7.6% (-0.7%)
- Procyon Advisors, LL: 4.0% (+158565.8%)
- Bank of America Corp: 3.1% (+0.6%)

### Key Risks

1. Valuation stretched: PEG 3.4x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.40 signals overvaluation risk, limited margin of safety. Forward P/E 26.0x stretched relative to 9% growth. Quality metrics strong (ROE 27%, margin 18%). Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $112.5B |
| Beta | 1.25 |
| 52W Range | $488.45 - $893.47 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.40 |
| Forward P/E | 26.0 |
| Current P/E | 28.4 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.6% to 1.1% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >4.0% for momentum thesis). MRS_5 (-0.6%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.59), confirming momentum. Volume at 46% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.14% (CS: 72) | Neutral |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 0.59 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.224x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $858.94
- **Stop Loss:** $822.30 (4.3% risk)
- **Target:** $895.58 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 13
- **Position Value:** $11,166.22
- **Portfolio %:** 11.17%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-29 (Est: $7.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.62 | $7.22 | +9.0% |
| 2025Q2 | $7.08 | $7.69 | +8.6% |
| 2025Q1 | $6.72 | $6.94 | +3.3% |
| 2024Q4 | $6.23 | $6.53 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*